⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GLMD News
Galmed Pharmaceuticals Ltd.
Galmed Announces Top-line Results in Oncology MoA Studies: A 3-drug combination of Aramchol, Stivarga® and Metformin Significantly Enhanced GI Tumor Cells, Killing In-vivo and In-vitro
prnewswire.com
GLMD
Galmed Announces Digital Asset Management Strategy to Enhance Capital Efficiency and Drive Shareholder Value
prnewswire.com
GLMD